Heparanase-2's Role in Cervical Cancer
Author Information
Author(s): Soboh Soaad, Vorontsova Avital, Farhoud Malik, Barash Uri, Naroditsky Inna, Gross-Cohen Miriam, Weissmann Marina, Yasuhiko Nishioka, Woolf Adrian S., Roberts Neil A., Shaked Yuval, Ilan Neta, Vlodavsky Israel
Primary Institution: Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel
Hypothesis
Heparanase-2 (Hpa2) functions as a tumor suppressor in cervical carcinoma.
Conclusion
High levels of Hpa2 are associated with prolonged survival in cervical cancer patients and reduced tumor growth.
Supporting Evidence
- High levels of Hpa2 correlate with prolonged survival of cervical carcinoma patients.
- Overexpression of Hpa2 in cervical carcinoma cells resulted in smaller tumor xenografts.
- Hpa2 plays a critical role in macrophage polarization.
- Macrophages lacking Hpa2 shifted towards a pro-tumorigenic M2 phenotype.
- BRD7 interacts with Hpa2 and is involved in its nuclear localization.
- High levels of Hpa2 staining correlate with lower tumor grades.
- Conditional Hpa2-KO mice showed increased tumor growth when co-implanted with Hpa2-KO macrophages.
Takeaway
Hpa2 helps keep cancer cells from growing too much, and having more of it can help patients live longer.
Methodology
The study used a tissue microarray of cervical carcinoma biopsies and conditional Hpa2-KO mice to assess the role of Hpa2.
Statistical Information
P-Value
p=0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website